Claudins are transmembrane proteins and major constitutes of tight junctions, and participate in the paracellular barrior and cellular connecting functions. They have been shown to be differentially regulated in malignant tumors and play a role in carcinogenesis and tumor progression. Recent studies have shown changes in expression of claudins during tumorigenesis. However, a causal relationship between claudin expression and cancer recurrent status has not been established. In this study, we examined 54 esophageal cancer cases to assess immunohistochemical expression patterns of claudin-1. Eleven (20.4%) of 54 cases had negative immunostaining for claudin-1. Decreased expression of claudin-1 was statistically correlated with recurrence status (P = 0.018). The cases with lymphatic vessel permeation showed reduced expression patterns of claudin-1 (P = 0.033). Decreased expression of claudin-1 was also correlated with short diseasefree survival (P = 0.0003) and overall survival (P = 0.0045). The results indicated that claudin-1 expression was correlated with the recurrence status and poor prognosis in esophageal cancer and claudin-1 expression may be a good indicator of recurrence in esophageal cancer.
Claudins are the recently discovered transmembrane proteins and the major components of tight junctions (3, 26) , with 24 members of the family identified to date. They are connected with the actin cytoskeleton and participate in intercellular signaling (8, 25) , and act as a primary barrier, preventing paracellular transport of solutes and irons, and also as diffusion barrier within plasma membranes. The claudins have been suggested to be associated with carcinogenesis and tumor progression. Alteration of claudins has been detected in carcinomas of the esophagus (6, 13, 15, 23, 28) , colorectum (14, 19) , and other cancers (16, 21, 24) , suggesting that the claudins are involved in the process of carcinogenesis (20) .
Esophageal cancer has been generally considered as one of the most extremely aggressive cancers with poor prognosis. Staging of the disease is most crucial parameter for predicting survival and recurrence (11) . The ability of tumor cells to survive and grow at metastatic sites increases the level of morbidity. Elucidating the mechanisms controlling invasion and metastasis in esophageal cancer may assist in identifying those patients at higher risk of metastases and mortality (17) . Several reports suggested that the claudins were correlated with esophageal cancer carcinogenesis. Significant increase in claudin-1 expression was detected in esophageal squamous cell carcinoma as compared with that in esophageal squamous epithelium (6) , and reduced expression of claudin-1 was significantly associated with histological differentiation of the tumor (28) . However, the relationship between the claudins and recurrence status of esophageal cancer has not yet 47-82) years. Seven tumors were in the upper thoracic esophagus, 26 in the middle thoracic esophagus and 21 in the lower thoracic or abdominal esophagus. The study in this paper was retrospective and followed the principles of the World Medical Association Declaration of Helsinki 1964.
Histopathological and immunohistochemical examinations. For routine histological examination, esophageal cancer specimens were routinely fixed with formalin, embedded in paraffin, thin-sectioned, and stained with hematoxylin and eosin (H&E). The pathological stage of each case at the time of operation was defined according to the TNM classification (22) , and each lesion was graded histologically according to the Guide Lines for Clinical and Pathologic Studies on Carcinoma of the Esophagus (9) .
In each patient, one representative histological specimen at the deepest invaded area of esophageal cancer lesion was selected for immunohistochemistry (12) . Four-μm-thick sections were mounted on silane-coated glass slides. First antibody of immunobeen analyzed.
In this study, we performed claudin-1 expression analysis in 54 esophageal squamous cell carcinomas in order to elucidate whether the claudin-1 expression is correlated with clinicopathological features and clinical outcomes.
MATERIALS AND METHODS
Patient's materials. Fifty-four squamous cell carcinomas of the thoracic and abdominal esophagus were studied, these carcinomas was surgically resected at Hirosaki University Hospital. Informed consent to use their clinical records and pathology specimens was obtained from all the patients. Patients underwent curative operations (R0) including subtotal esophagectomy and dissection of lymph nodes (22) . No patients had received radiotherapy or chemotherapy before operation, but 27 patients had received postoperative radiotherapy and/or chemotherapy when cancer recurred. The series consisted of 48 men and six women of mean age 65 (range ( Fig. 1) . In normal squamous epithelium as a control, claudin-1 gave a membranous reaction showing a honeycomb appearance (6) .
Statistical analysis. Statistical analyses of immunostaining were performed using the χ 2 test or Fisher's exact probability test. Survival curves were calculated by the Kaplan-Meier method and analyzed by the log-rank test. P values less than 0.05 were considered to indicate statistical significance. All statistical analyses were performed using SPSS software (version 11.0; SPSS, Inc., Chicago, IL, USA).
RESULTS
The relationship between the claudin-1 expression and clinicopathological features were summarized in Table 1 . Typical immunohistochemical expression histochemistry was anti-claudin-1 antibody (rabbit polyclonal, 1 : 100 dilution; Zymed Laboratories Inc., South San Francisco, CA). Section for claudin-1 was pretreated with autoclave heating (121°C, 10 min) for antigen retrieval. The staining was performed using the streptavidin biotin-peroxidase procedure with a Histofine kit (Nichirei Co., Tokyo, Japan), according to the manufacturer's instructions. All sections were incubated overnight at 4°C. The sections were reacted with a 3, 3'-diaminobenzidinetetrahydrochloride (Merck KGaA, Darmstadt, Germany), and counter-stained with hematoxylin.
Evaluation of immunostaining patterns of claudin-1.
Staining patterns of claudin-1 expression were divided into the following two groups: negative 10% of membrane staining in tumor cells and positive > 10% of membrane staining in tumor cells *statistical significance permeation (P = 0.198). Claudin-1-positive cases were significantly less frequent in recurrent cases, compared to non-recurrent cases (P = 0.018). Calculation of the survival curves by the Kaplan-Meier method revealed that negative claudin-1 expression was correlated with early recurrent status (P = 0.0003) and poor prognosis (P = 0.0045) (Fig. 2) . The claudin-1 expression was decreased in 20.4% (11 of 54) of the esophageal squamous cell carcinomas we examined. The claudin-1 expression was regardless of the tumor invasion by the TNM classification (T1 to T4). On the other hand, there was a tendency to decrease the claudin-1 expression in infiltrative growth pattern, compared to the expansive growth (P = 0.062). However, the histopathological grade (well, moderately and poorly differentiated types) were not associated with the claudin-1 expression. The claudin-1 expression was significantly decreased in the cases with lymphatic vessel permeation (P = 0.033). In addition, there was a tendency to reduced the claudin-1 expression in the cases with venous clarified in the esophagus extensively. In addition, only several studies examined claudins expression in the esophageal diseases including cancers (6, 13, 15, 23, 28) . In this study, we demonstrated that decreased expression of claudin-1 was correlated with the recurrence status in esophageal squamous cell carcinoma, and associated with short disease-free survival and overall survival. This is the first study to elucidate relationships between the claudin-1 expression and clinical outcomes of esophageal squamous cell carcinomas.
It is widely accepted that cell-to-cell adhesiveness is generally reduced in various human cancers. The dissociation of cancer cells from the primary cancer nests is a crucial step in metastasis (7) . Cell-to-cell adhesiveness within the epithelial cell layer is mainly constituted by adherens junction and tight junction. The claudins have been showed as proteins responsible for the tight junction (4), the expression of which depends on cell type and tissue (2, 10, 27) . In stage II colon cancer, reduced expression of claudin-1 was significantly associated with poorly differentiated tumors and a strong predictor of disease recurrence and poor patient survival using tissue microarray technology (19) . In addition, decreased expression of claidin-1 was correlated with recurrence status in breast cancer (16) . These studies suggest that the claudin-1 expression might be a useful indicator of cancer recurrence. The present study demonstrated that decreased expression of claudin-1 is statistically associated with recurrence status of esophageal cancer.
Squamous cell carcinoma is the most common type of malignant tumor of the esophagus. Many cases are advanced tumors with lymph node metastases at the time of diagnosis because it is difficult to detect in early stage (5) . Clinicopathological features such as depth of invasion and lymph node status have been associated with prognosis of esophageal cancer (1, 18) . Staging of the disease is the most crucial parameter for predicting survival and recurrence (11) . Further studies of prognostic factors are still necessary in esophageal cancer because the esophageal cancer prognosis is correlated not only with the staging systems. Recurrence is the most frequent cause of fatality in cancer patients. The recurrent cases have much more metastatic potential than non-recurrent cases.
Recently, two different studies have been reported; one report described that significant association was not detected between the claudin-1 expression and clinicopathological factors except for histological differentiation of the tumor (28) , and another study reported that the claudin-1 expression was not associated with clinicopathological features including tumor grade, tumor size, T-stage, presence of lymph nodal and distal metastases (23) . The discrepancies between our results and these studies are thought to result from the methods for the evaluation of immunoreactivities. The former study evaluated the expression of claudin-1 by degree of expression (28) , the latter examined it using 50% of positive expression as the cutoff point (23) . We observed the deepest tumor advanced margins and used 10% as the claudin-1 cutoff point for evaluation criteria (Fig. 1) , and examined the relationship between the claudin-1 expression and clinicopathological features. The present study demonstrated that decreased expression of claudin-1 correlated with recurrence status and lymphatic vessel permeation. We speculated that claudin-1 might affect the permeation of the lymphatic vessels, and play a role in the recurrent status.
In conclusion, our study provides that decreased expression of claudin-1 is correlated with recurrence status and poor prognosis in esophageal squamous cell carcinoma. Therefore, we consider that the expression of claudin-1 may be a novel predictor of recurrence and prognosis.
